Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors

Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors
复制标题

DOI:
10.1038/s41598-017-10212-5
复制
发表时间:
2017-08-30
期刊:
影响因子:
4.6
通讯作者:
Das, Payel
Das, Payel
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Chakraborty, Srirupa;Das, Payel

文献摘要

被引文献

相似文献

阿尔茨海默病(AD)的特征在于淀粉样蛋白β(A β)肽沉积到脑中的老年斑中。虽然大多数家族性突变与早发性AD相关,但最近的研究报告了两种遗传性人类A β变体(即A2 T和A2 V)在杂合状态下的AD保护性质。还发现A2 V A β 1-6(A β(6))六肽和WT A β 1-42(A β(42))的混合物具有神经保护作用。受这些发现的启发,在这项研究中,我们研究了WT,A2 V和A2 T A β(6)六肽结合对单体WT A β(42)景观的影响。为此目的,我们进行了广泛的原子交换分子动力学模拟,阐明了与WT A β(6)相比,A β(42)与A2 V和A2 T六肽的优先结合。由于六肽缔合,揭示了A β(42)景观的显著重组,如通过降低中央和C-末端疏水斑块之间的瞬时相互作用所表现的。同时,A β 6结合的A β(42)单体表现出强烈依赖于六肽序列的替代结构特征。例如,中心螺旋更频繁地在A2 T结合的单体内聚集,而A2 V结合的A β(42)通常在整体病症中增强。总之,本模拟提供了新的分子见解的N-末端六肽结合的影响,A β(42)单体结构,这可能有助于解释其报告的淀粉样蛋白抑制性能。
Alzheimer's disease (AD) is characterized by deposition of amyloid beta (A beta) peptides into senile plaques in the brain. While most familial mutations are associated with early-onset AD, recent studies report the AD-protective nature of two genetic human A beta variants, i.e. A2T and A2V, in the heterozygous state. The mixture of A2V A beta 1-6 (A beta(6)) hexapeptide and WT A beta 1-42 (A beta(42)) is also found neuroprotective. Motivated by these findings, in this study we investigate the effects of WT, A2V, and A2T A beta(6) hexapeptide binding on the monomeric WT A beta(42) landscape. For this purpose, we have performed extensive atomistic Replica Exchange Molecular Dynamics simulations, elucidating preferential binding of A beta(42) with the A2V and A2T hexapeptides compared to WT A beta(6). A notable reorganization of the A beta(42) landscape is revealed due to hexapeptide association, as manifested by lowering of transient interactions between the central and C-terminal hydrophobic patches. Concurrently, A beta 6-bound A beta(42) monomer exhibits alternative structural features that are strongly dependent on the hexapeptide sequence. For example, a central helix is more frequently populated within the A2T-bound monomer, while A2V-bound A beta(42) is often enhanced in overall disorder. Taken together, the present simulations offer novel molecular insights onto the effect of the N-terminal hexapeptide binding on the A beta(42) monomer structure, which might help in explaining their reported amyloid inhibition properties.